-
1
-
-
0027513298
-
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study
-
Bajorin DF, Sarosdy MF, Pfister DG, et al: Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: A multiinstitutional study. J Clin Oncol 11:598-606, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 598-606
-
-
Bajorin, D.F.1
Sarosdy, M.F.2
Pfister, D.G.3
-
2
-
-
0023195303
-
Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide
-
Williams SD, Birch R, Einhorn LH, et al: Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316:1435-1440, 1987
-
(1987)
N Engl J Med
, vol.316
, pp. 1435-1440
-
-
Williams, S.D.1
Birch, R.2
Einhorn, L.H.3
-
3
-
-
0025875021
-
Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol
-
Nichols CR, Williams SD, Loehrer PJ, et al: Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: A Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 9:1163-1172, 1991
-
(1991)
J Clin Oncol
, vol.9
, pp. 1163-1172
-
-
Nichols, C.R.1
Williams, S.D.2
Loehrer, P.J.3
-
4
-
-
0025613902
-
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors
-
Motzer RJ, Cooper K, Geller NL, et al: The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors. Cancer 66:2476-2481, 1990
-
(1990)
Cancer
, vol.66
, pp. 2476-2481
-
-
Motzer, R.J.1
Cooper, K.2
Geller, N.L.3
-
5
-
-
0027057141
-
Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience
-
Motzer RJ, Bajorin DF, Vlamis V, et al: Ifosfamide-based chemotherapy for patients with resistant germ cell tumors: The Memorial Sloan-Kettering Cancer Center experience. Semin Oncol 19:8-12, 1992
-
(1992)
Semin Oncol
, vol.19
, pp. 8-12
-
-
Motzer, R.J.1
Bajorin, D.F.2
Vlamis, V.3
-
6
-
-
0023695848
-
Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide
-
Loehrer PJ, Lauer R, Roth BJ, et al: Salvage therapy in recurrent germ cell cancer: Ifosfamide and cisplatin plus either vinblastine or etoposide. Ann Intern Med 109:540-546, 1988
-
(1988)
Ann Intern Med
, vol.109
, pp. 540-546
-
-
Loehrer, P.J.1
Lauer, R.2
Roth, B.J.3
-
7
-
-
0029877985
-
Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients
-
Farhat F, Culine S, Theodore C, et al: Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients. Cancer 77:1193-1197, 1996
-
(1996)
Cancer
, vol.77
, pp. 1193-1197
-
-
Farhat, F.1
Culine, S.2
Theodore, C.3
-
8
-
-
0007259603
-
Long term followup of second line chemotherapy with vinblastine, ifosfamide and cisplatin in disseminated germ cell tumors
-
abstr
-
Einhorn LH, Weathers T, Loehrer P, et al: Long term followup of second line chemotherapy with vinblastine, ifosfamide and cisplatin in disseminated germ cell tumors. Proc Am Soc Clin Oncol 15:240, 1996 (abstr)
-
(1996)
Proc Am Soc Clin Oncol
, vol.15
, pp. 240
-
-
Einhorn, L.H.1
Weathers, T.2
Loehrer, P.3
-
9
-
-
0026504386
-
Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ cell tumors. Long-term results
-
Pizzocaro G, Salvioni R, Piva L, et al: Modified cisplatin, etoposide (or vinblastine) and ifosfamide salvage therapy for male germ cell tumors. Long-term results. Ann Oncol 3:211-216, 1992
-
(1992)
Ann Oncol
, vol.3
, pp. 211-216
-
-
Pizzocaro, G.1
Salvioni, R.2
Piva, L.3
-
10
-
-
0000560759
-
Phase III study of cisplatin, etoposide and bleomycin (PVP16B) or etoposide, ifosfamide and cisplatin (VIP) in advanced stage germ cell tumors: An intergroup trial
-
abstr
-
Nichols CR, Loehrer PJ, Einhorn LH, et al: Phase III study of cisplatin, etoposide and bleomycin (PVP16B) or etoposide, ifosfamide and cisplatin (VIP) in advanced stage germ cell tumors: An intergroup trial. Proc Am Soc Clin Oncol 14:239, 1995 (abstr)
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 239
-
-
Nichols, C.R.1
Loehrer, P.J.2
Einhorn, L.H.3
-
11
-
-
0026459668
-
High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions
-
Motzer RJ, Bosl GJ: High-dose chemotherapy for resistant germ cell tumors: Recent advances and future directions. J Natl Cancer Inst 84:1703-1709, 1992
-
(1992)
J Natl Cancer Inst
, vol.84
, pp. 1703-1709
-
-
Motzer, R.J.1
Bosl, G.J.2
-
12
-
-
0028896184
-
Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: A randomized trial
-
Bajorin DF, Nichols CR, Schmoll H, et al: Recombinant human granulocyte-macrophage colony-stimulating factor as an adjunct to conventional-dose ifosfamide-based chemotherapy for patients with advanced or relapsed germ cell tumors: A randomized trial. J Clin Oncol 13:79-86, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 79-86
-
-
Bajorin, D.F.1
Nichols, C.R.2
Schmoll, H.3
-
13
-
-
0026087605
-
Salvage chemotherapy for patients with germ cell tumors. the Memorial Sloan-Kettering Cancer Center experience (1979-1989)
-
Motzer RJ, Geller NL, Tan CC, et al: Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989). Cancer 67:1305-1310, 1991
-
(1991)
Cancer
, vol.67
, pp. 1305-1310
-
-
Motzer, R.J.1
Geller, N.L.2
Tan, C.C.3
-
14
-
-
0028860147
-
Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial
-
Loehrer P, Johnson D, Elson P, et al: Importance of bleomycin in favorable-prognosis disseminated germ cell tumors: An Eastern Cooperative Oncology Group trial. J Clin Oncol 13:470-476, 1995
-
(1995)
J Clin Oncol
, vol.13
, pp. 470-476
-
-
Loehrer, P.1
Johnson, D.2
Elson, P.3
-
15
-
-
0029737635
-
Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapy
-
Motzer RJ: Selecting patients with cisplatin-resistant germ cell tumors for high-dose chemotherapy. J Clin Oncol 14:2625-2626, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 2625-2626
-
-
Motzer, R.J.1
-
16
-
-
0029928705
-
High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity
-
Motzer RJ, Mazumdar M, Bosl GJ, et al: High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: Treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14:1098-1105, 1996
-
(1996)
J Clin Oncol
, vol.14
, pp. 1098-1105
-
-
Motzer, R.J.1
Mazumdar, M.2
Bosl, G.J.3
-
17
-
-
0343889015
-
Tandem autotransplantation for initial relapse of germ cell cancer
-
abstr
-
Broun ER, Gize G, Nichols CR, et al: Tandem autotransplantation for initial relapse of germ cell cancer. Proc Am Soc Clin Oncol 14:243, 1995 (abstr)
-
(1995)
Proc Am Soc Clin Oncol
, vol.14
, pp. 243
-
-
Broun, E.R.1
Gize, G.2
Nichols, C.R.3
-
18
-
-
0027996483
-
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors
-
Motzer RJ, Bajorin DF, Schwartz LH, et al: Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors. J Clin Oncol 12:2277-2283, 1994
-
(1994)
J Clin Oncol
, vol.12
, pp. 2277-2283
-
-
Motzer, R.J.1
Bajorin, D.F.2
Schwartz, L.H.3
-
19
-
-
0028033791
-
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer
-
Bokemeyer C, Schmoll H, Natt F, et al: Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer. J Cancer Res Clin Oncol 120:754-757, 1994
-
(1994)
J Cancer Res Clin Oncol
, vol.120
, pp. 754-757
-
-
Bokemeyer, C.1
Schmoll, H.2
Natt, F.3
|